Lanoiselée, J.; Mourer, J.; Jungling, M.; Molliex, S.; Thellier, L.; Tabareau, J.; Jeanpierre, E.; Robin, E.; Susen, S.; Tavernier, B.;
et al. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis. Pharmaceutics 2024, 16, 770.
https://doi.org/10.3390/pharmaceutics16060770
AMA Style
Lanoiselée J, Mourer J, Jungling M, Molliex S, Thellier L, Tabareau J, Jeanpierre E, Robin E, Susen S, Tavernier B,
et al. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis. Pharmaceutics. 2024; 16(6):770.
https://doi.org/10.3390/pharmaceutics16060770
Chicago/Turabian Style
Lanoiselée, Julien, Jérémy Mourer, Marie Jungling, Serge Molliex, Lise Thellier, Julien Tabareau, Emmanuelle Jeanpierre, Emmanuel Robin, Sophie Susen, Benoit Tavernier,
and et al. 2024. "Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis" Pharmaceutics 16, no. 6: 770.
https://doi.org/10.3390/pharmaceutics16060770
APA Style
Lanoiselée, J., Mourer, J., Jungling, M., Molliex, S., Thellier, L., Tabareau, J., Jeanpierre, E., Robin, E., Susen, S., Tavernier, B., Vincentelli, A., Ollier, E., & Moussa, M. D.
(2024). Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis. Pharmaceutics, 16(6), 770.
https://doi.org/10.3390/pharmaceutics16060770
